Figure 2 | British Journal of Cancer

Figure 2

From: Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

Figure 2

(A) Disease-specific survival of all cases according to Bcl-2 expression. (B) Disease-specific survival in Bcl-2-negative cases only according to the response to immunotherapy. (C) Disease-specific survival of all cases according to Fas expression. (D) Disease-specific survival in Fas-negative cases only according to the response to immunotherapy. (E) Comparison of disease-specific survival between CR+PR vs NC+PD. (F) Comparison of disease-specific survival between Bcl-2 and Fas-negative cases in CR+PR vs others.

Back to article page